GENENTECH, INC. v AMRAD Corporation Limited

Link copied
Case Copied 14 min read

official notice

decision of a delegate of the commissioner of patents

Application        :  No. 638839 in the name of GENENTECH INC.

Title:  METHOD AND COMPOSITION FOR TREATING INJURY

Action:  Application by AMRAD CORPORATION LIMITED for an extension of time in which to file a notice of opposition

Decision:  Issued            .   Extension allowed. Error or omission by AMRAD Corporation Limited.

patents act 1990

decision of a delegate of the commissioner of patents

Re: Patent Application No. 638839 by GENENTECH, INC. and a

request under S 223 of the Patents Act 1990 for an

extension of time in which to file a notice of opposition.

BACKGROUND

GENENTECH, INC. (hereafter referred to as GENENTECH) lodged application number 638839 as PCT/US91/02446 on 9 April 1991 under the provisions of the Patent Cooperation Treaty(PCT). That application was published under the PCT as WO9115227, and in Australia was allocated the application number 78565/91. 78565/91 was advertised open to public inspection on 5 December 1991, advertised accepted on 8 July 1993, and given the number 638839.

A person intending to oppose the grant of a patent under S 59 of the act must file a notice of opposition within three months of the publication of the notice of acceptance in the Official Journal of Patents(AOJP)(Reg 5.3 (1)). Thus the time limit for filing a notice of opposition in this case was 8 October 1993.

On 19 October 1993 AMRAD CORPORATION LIMITED (hereafter referred to as AMRAD) filed a notice of opposition simultaneously with a request for an extension of time under S 223 of the Patents Act in which to file the notice of opposition.

GENENTECH asked for and was granted an extension of time in which to file an objection to the AMRAD request for an extension of time. GENENTECH filed this objection on 2 December 1993 objecting to any allowance of an extension of time under S 223 in which to file a notice of opposition.

A hearing on this matter was held in Canberra on 10 January 1994. AMRAD was represented by Mr. PAUL JONES of PHILLIPS ORMONDE & FITZPATRICK and GENENTECH was represented by Dr. VIVIEN SANTER of GRIFFITH HACK & CO.

THE APPLICATION FOR AN EXTENSION OF TIME

AMRAD filed a statutory declaration setting out the circumstances and grounds for an extension of time on 5 November 1993 and a supplementary statutory declaration on 13 December 1993, both made by Mr. Robert J. Klupacs, Intellectual Property Manager, AMRAD CORPORATION LIMITED.

The first declaration sets out the reasons why the notice of opposition was not filed within the prescribed period, while the second expands upon statements made in the first declaration.

I have summarised the reasons given in the declarations as follows:

.     Mr. Klupacs states that he holds, inter alia, a post-
     graduate diploma in intellectual property law from the                  
     University of Melbourne and has either been granted
     exemptions, or has passed, several subjects in the
     examinations of the Patent Attorneys Professional Standards
     Board.

.     Mr. Klupacs…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read GENENTECH, INC. v AMRAD Corporation Limited and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[1994] APO 17
Decision Date

CaseChat Overview and Summary

The matter of Genentech, Inc. v AMRAD Corporation Limited involves a dispute over the granting of a patent for a method and composition for treating injury. The case was heard by a delegate of the Commissioner of Patents. The primary legal issue was whether AMRAD Corporation Limited's request for an extension of time to file a notice of opposition against Genentech's patent application should be granted. The court needed to determine if AMRAD's delay in filing the notice of opposition was due to an error or omission and if the extension should be allowed under section 223 of the Patents Act 1990.

The court found that AMRAD's Intellectual Property Manager, Mr. Robert Klupacs, had indeed made an error of judgment by relying solely on Dialog/WPI to alert him of any changes in the status of the patent application. This reliance caused a delay in filing the notice of opposition, which was not filed within the prescribed three-month period. The court concluded that this error or omission was causally connected to the failure to file the notice of opposition on time. Furthermore, the court found that AMRAD had made out a proper case justifying an extension of time and that the private and public interests were best served by allowing the extension. The opposition was considered serious, as AMRAD had identified the application and formed the intention to oppose by April 1992.

In light of these findings, the court granted the extension of time under section 223(2)(a) until 19 October 1993 to file a notice of opposition, and awarded costs against Genentech.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.